Adial Pharmaceuticals, Inc. Finance Lease, Liability
Adial Pharmaceuticals, Inc. (ADIL) had Finance Lease, Liability of $256.96 thousand as of 2021-12-31, per its 10-Q filed 2022-08-15.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:FinanceLeaseLiability · last filed 2022-08-15
- 2021-12-31: Finance Lease, Liability $256.96K.
| Period end | Finance Lease, Liability |
|---|---|
| 2021-12-31 | $256.96K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |